Clinical Trial

This Study Aims to Evaluate the Efficacy and Safety of QLS1317 in Patients With MSI-H/dMMR Advanced Solid Tumors.

Name: This Study Aims to Evaluate the Efficacy and Safety of QLS1317 in Patients With MSI-H/dMMR Advanced Solid Tumors. — clinical trial record (NCT07552376)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The goal of this study aims to evaluate the efficacy and safety of QLS1317 in patients with MSI-H/dMMR advanced solid tumors who failed standard treatment.

Trial Details

NCT Number	NCT07552376
Lead Sponsor	Shanghai Qilu Pharmaceutical Research and Development Center LTD
Conditions	MSI-H or dMMR Advanced Solid Tumors
Enrollment	120 participants
Start Date	2026-05
Primary Completion	2028-06 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-27